TB Alliance and Unitaid released a report, New pathways for childhood TB treatment: Lessons from the STEP-TB project, documenting how the STEP-TB project has reshaped the market for pediatric TB drugs by reducing barriers to entry, engaging in innovative industry collaboration to launch optimized products for children, and mobilizing strong demand. Since launching in 2015, these new medicines have begun to reach children around the world, setting a precedent for future action in the fight to end TB.